C. Hammond

Erratum to: The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study

Mahboob Rahman, S. Kotak, R. Burgos-Vargas, 2016, Arthritis Research & Therapy.

Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial

J. Kremer, J. Isaacs, E. Nasonov, 2015, Arthritis Research & Therapy.

The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study

Khalid Shirazy, H. Jones, R. Pedersen, 2018, Rheumatology and Therapy.

The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: a multinational, multicenter study

Mahboob Rahman, S. Kotak, M. Hammoudeh, 2016, Arthritis Research & Therapy.

Reversibility of peripheral blood leukocyte phenotypic and functional changes after exposure to and withdrawal from tofacitinib, a Janus kinase inhibitor, in healthy volunteers.

J. D. Clark, P. Biswas, K. Weinhold, 2018, Clinical immunology.

Bumetanide to Treat Parkinson Disease: A Report of 4 Cases.

P. Damier, C. Hammond, Y. Ben-Ari, 2016, Clinical neuropharmacology.

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

K. Pavelka, P. Miranda, J. Smolen, 2013, The Lancet.

Efficacy and safety of erdafitinib in adults with cholangiocarcinoma (CCA) with prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase 2 open-label, single-arm RAGNAR trial: Expansion cohort results.

G. Iyer, J. Tabernero, G. Folprecht, 2023, Journal of Clinical Oncology.